New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

BACKGROUND: Amyloid precursor protein (APP), a key molecule in Alzheimer’s disease (AD), is metabolized in two alternative cleavages, generating either the amyloidogenic peptides involved in AD pathology or the soluble form of APP (sAPPα). The level of amyloidogenic peptides in human cerebrospinal f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rose, Christiane, Peoc’h, Katell, Chasseigneaux, Stéphanie, Paquet, Claire, Dumurgier, Julien, Bourasset, Fanchon, Calon, Frédéric, Laplanche, Jean-Louis, Hugon, Jacques, Allinquant, Bernadette
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2012
Materias:
Methodology Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3418197/
https://ncbi.nlm.nih.gov/pubmed/22824057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-13-84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares